Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis

NCT00216333 is registered in ClinicalTrials.gov with International Union Against Tuberculosis and Lung Diseases as lead sponsor.

NCT NCT00216333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00216333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicenter Trial for the Evaluation of a Four-Drug Fixed Dose Combined Tablet Daily in the Initial Intensive Phase of Chemotherapy Followed by a Two-Drug Fixed Dose Combined Tablet Three Times a Week in the Continuation Phase for the Treatment of Pulmonary Tuberculosis
Lead sponsor
International Union Against Tuberculosis and Lung Diseases
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2003
Completion date
June 30, 2007
Enrollment
1,500
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis